Sanofi

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. 

CEO
Belén Garijo López
CEOBelén Garijo López
Employees
76,493
Employees76,493
Headquarters
Paris, Ile-de-France
HeadquartersParis, Ile-de-France
Founded
1973
Founded1973
Employees
76,493
Employees76,493

SNY Key Statistics

Market cap
100.14B
Market cap100.14B
Price-Earnings ratio
21.14
Price-Earnings ratio21.14
Dividend yield
4.28%
Dividend yield4.28%
Average volume
2.94M
Average volume2.94M
High today
$42.06
High today$42.06
Low today
$41.62
Low today$41.62
Open price
$41.88
Open price$41.88
Volume
1.96M
Volume1.96M
52 Week high
$52.68
52 Week high$52.68
52 Week low
$40.40
52 Week low$40.40

SNY News

The Wall Street Journal 3h
Health Care Roundup: Market Talk

Yves Herman / Reuters The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET....

Health Care Roundup: Market Talk
TipRanks 4h
Regeneron, Sanofi expand long-standing antibody collaboration

Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) announced an expansion of their long-standing antibody collaboration, adding multiple next-generation, long-ac...

Reuters 4h
Breakingviews - COMMENTARY: Sanofi’s Regeneron fix requires extra shot of M&A - Reuters

...

Breakingviews - COMMENTARY: Sanofi’s Regeneron fix requires extra shot of M&A - Reuters

Analyst ratings

50%

of 8 ratings
Buy
50%
Hold
50%
Sell
0%

More SNY News

The Wall Street Journal 7h
Sanofi, Regeneron to Expand Alliance in Deal Valued at Up to $8 Billion

A prior litigation related to the collaboration was settled as part of the agreement, the companies said. Sylvain Thomas / Agence France-Presse / Getty Images...

Sanofi, Regeneron to Expand Alliance in Deal Valued at Up to $8 Billion
TipRanks 8h
Sanofi and Regeneron Deepen $8 Billion Immunology Alliance for Next-Gen Antibodies

Sanofi ( (FR:SAN) ) has issued an update. Sanofi and Regeneron have expanded their two-decade immunology alliance by adding four next-generation, long-acting a...

TipRanks 2d
Sanofi’s Teplizumab Study Signals a New Front in Pediatric Type 1 Diabetes

Sanofi SA (SNY) announced an update on their ongoing clinical study. Sanofi’s latest clinical update centers on a Phase 4 study called “Single Arm, Open-label...

TipRanks 6d
Sanofi India Faces GST Show Cause Notice Over Input Tax Credit Claims

The latest update is out from Sanofi India Limited ( (IN:SANOFI) ). Sanofi India Limited has disclosed that it received a show cause notice from Karnataka GST...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.